Related Experiment Video
Updated: Aug 6, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
[Osteoprotegerin and calcium-phosphorus metabolism parameters in children with chronic renal failure]
Helena Ziółkowska1, Maria Roszkowska-Blaim
1Katedra i Klinika Pediatrii i Nefrologii, Akademii Medycznej w Warszawie. nefrologia@litewska.edu.pl
Insights
Elevated osteoprotegerin (OPG) levels in children with end-stage renal disease (ESRD) may indicate increased bone turnover. This study investigated OPG and calcium-phosphorus metabolism in pediatric chronic kidney disease.
Area of Science:
- Biochemistry
- Pediatric Nephrology
- Bone Metabolism
Context:
- Chronic kidney disease (CKD) in children significantly impacts bone health.
- Osteoprotegerin (OPG), a key regulator of bone turnover and vascular calcification, is implicated in CKD.
- Understanding OPG's role in pediatric CKD is crucial for managing bone complications.
Purpose:
- To investigate the correlation between serum osteoprotegerin (OPG) levels and parameters of calcium-phosphorus metabolism in children with chronic renal failure (CRF) and end-stage renal disease (ESRD).
- To compare OPG levels in pediatric CRF and ESRD patients with healthy controls.
- To explore the relationship between OPG, parathyroid hormone (PTH), and bone turnover markers.
Summary:
- Serum OPG concentrations were significantly higher in children with ESRD compared to controls.
- OPG levels did not correlate with creatinine in CRF patients but showed a correlation with osteocalcin (OC) in ESRD patients.
- In combined CRF and ESRD groups, OPG correlated with PTH, cyclase-activating PTH (CAP), cyclase-inactive PTH (CIP), and OC, particularly in patients with higher PTH levels.
Impact:
- Findings suggest elevated OPG in pediatric ESRD reflects heightened bone turnover.
- This research provides insights into the complex interplay of OPG, mineral metabolism, and bone disease in pediatric CKD.
- Results may inform future therapeutic strategies targeting bone health in children with renal insufficiency.
Unlabelled:
Osteoprotegerin (OPG), a member of the TNF receptor superfamily is a natural inhibitor of osteoclastogenesis and important inhibitor of vascular calcification. The aim of the study was to estimate a correlation of serum OPG level and the other parameters calcium-phosphorus metabolism in children with chronic renal failure. Seventy four children with chronic renal insufficiency, 48 on conservative treatment (CRF) aged 13 +/- 3 years with creatinine clearance 45 +/- 21 ml/min/1.73m2 and 26 with end-stage renal disease (ESRD) aged 14 +/- 5 years were examined. The control group (K) consisted of 23 healthy children aged 10.8 +/- 3 years. In all children serum concentration of OPG, calcium (sCa), phosphorus (sP), PTH, CAP (cyclase activating PTH), CIP (cyclase inactive PTH) and osteocalcin (OC) were measured. OPG was determined by ELISA method (Biomedica), PTH and OC by IRMA (Duo-PTH, Scantibodies, USA and Osteo-Riact firm CIS, F).
Results:
The concentration of OPG was higher in ESRD group (3 +/-1.6 pmol/l) than in K (1.95 +/- 0.56 pmol/l), p<0.005. The concentration of OPG in CRF group (2.42 +/- 1.4 pmol/l) was not different from this in K and ESRD. The concentration of OPG did not correlate with serum creatinine level. In CRF group no correlation was found between OPG level and the other parameters, in group ESRD the significant correlation between OPG and OC was found (R=0.55, p=0.006). The level of OPG in children CRF + ESRD correlated with PTH concentration (R=0.27, p<0.03), CAP (R=0.29, p<0.02), CIP (R=0.23, p<0.05) and OC (R=0.25, P<0.04). In patients with higher PTH level (> 200 pg/ml) the higher correlations between OPG and PTH, CAP and CIP were found. No significant correlation between PTH and OPG in patients with lower PTH level (< 200 pg/ ml) was found. No significant correlation between OPG and OC in patients with lower and higher PTH was found.
Conclusion:
The elevated levels of OPG in children with ESRD may reflect the higher bone turnover in these patients.
Related Concept Videos
Skeleton and Calcium Homeostasis
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Osteoclasts in Bone Remodeling
Bone Remodeling
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
